Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06144229Enrolling By Invitation

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

Role: collaborator

NCT03842995Not ApplicableCompleted

South-seq: Deoxyribonucleic Acid (DNA) Sequencing for Newborn Nurseries in the South

Role: collaborator

NCT04614623Not ApplicableUnknown

Defining the Role of Management Factors in Outcome Disparity in Pediatric T1D

Role: lead

All 3 trials loaded